Home > Annual Financials > AUROBINDO PHARMA

AUROBINDO PHARMA Financial Statement Analysis
[BOM: 524804|NSE : AUROPHARMA]

The Revenues of AUROBINDO PHARMA have increased by 5.97% YoY .
The Earnings Per Share (EPS) of AUROBINDO PHARMA has decreased by -27.21 % YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

AUROBINDO PHARMA Last 5 Annual Financial Results
[BOM: 524804|NSE : AUROPHARMA]

ConsolidatedMar2023
Mar2022
Mar2021
Mar2020
Mar2019
Revenues ₹24,855 Cr₹23,455 Cr₹24,775 Cr₹23,099 Cr₹19,564 Cr
Expenses ₹21,137 Cr₹19,071 Cr₹19,441 Cr₹18,234 Cr₹15,612 Cr
Operating Profit (Excl OI) ₹3,719 Cr₹4,385 Cr₹5,333 Cr₹4,864 Cr₹3,952 Cr
Other Income ₹291 Cr₹323 Cr₹381 Cr₹192 Cr₹155 Cr
Interest ₹140 Cr₹49 Cr₹74 Cr₹305 Cr₹263 Cr
Depreciation ₹1,245 Cr₹1,127 Cr₹1,055 Cr₹967 Cr₹668 Cr
Profit Before Tax ₹2,613 Cr₹3,373 Cr₹7,344 Cr₹3,743 Cr₹3,089 Cr
Profit After Tax ₹1,928 Cr₹2,647 Cr₹5,334 Cr₹2,844 Cr₹2,362 Cr
Consolidated Net Profit ₹1,928 Cr₹2,648 Cr₹5,335 Cr₹2,845 Cr₹2,365 Cr
Earnings Per Share (Rs)₹32.90₹45.20₹91.05₹48.56₹40.36
PAT Margin (%)3.795.5410.986.025.89
ROE(%)7.5011.3827.5318.5218.47
ROCE(%)9.3912.7130.1018.7217.97
Total Debt/Equity(x)0.180.100.230.330.50

Key Financials

Market Cap : ₹ 59,612.4 Cr
Revenue (TTM) : ₹ 27,894.7 Cr
Net Profit(TTM) : ₹ 2,777.9 Cr
EPS (TTM) : ₹ 47.4
P/E (TTM) : 21.5

Industry Peers & Returns1W1M1Y
AUROBINDO PHARMA -2.6% -1.6% 122.3%
SUN PHARMACEUTICAL INDUSTRIES -0.8% 4% 61.6%
DIVIS LABORATORIES -2.1% -6% 26.4%
CIPLA 1.5% 3.3% 70.6%
DR REDDYS LABORATORIES 0.7% 0.4% 44.6%
TORRENT PHARMACEUTICALS -4% -2.8% 70.3%
ABBOTT INDIA 6% -3% 39.7%
ZYDUS LIFESCIENCES 0.3% 11.1% 109.1%
ALKEM LABORATORIES -1.5% -8.6% 63.1%


AUROBINDO PHARMA Revenues
[BOM: 524804|NSE : AUROPHARMA]

Y-o-Y

5.97 %

5 Yr CAGR

6.17 %

Years Revenues % Change
Mar2023 ₹24,855 Cr
5.97
Mar2022 ₹23,455 Cr
-5.32
Mar2021 ₹24,775 Cr
7.26
Mar2020 ₹23,099 Cr
18.07
Mar2019 ₹19,564 Cr -


AUROBINDO PHARMA Operating Profit
[BOM: 524804|NSE : AUROPHARMA]

Y-o-Y

-15.19 %

5 Yr CAGR

-1.51 %

Years Operating Profit % Change
Mar2023 ₹3,719 Cr
-15.19
Mar2022 ₹4,385 Cr
-17.79
Mar2021 ₹5,333 Cr
9.64
Mar2020 ₹4,864 Cr
23.09
Mar2019 ₹3,952 Cr -

Operating Margins
Y-o-Y

-19.96 %

5 Yr CAGR

-7.23 %

Years Operating Margin% % Change
Mar2023 14.96%
-19.96
Mar2022 18.69%
-13.19
Mar2021 21.53%
2.23
Mar2020 21.06%
4.26
Mar2019 20.2% -

AUROBINDO PHARMA Profit After Tax
[BOM: 524804|NSE : AUROPHARMA]

Y-o-Y

-27.21 %

5 Yr CAGR

-4.98 %

Years Profit After Tax % Change
Mar2023 ₹1,928 Cr
-27.21
Mar2022 ₹2,648 Cr
-50.36
Mar2021 ₹5,335 Cr
87.51
Mar2020 ₹2,845 Cr
20.32
Mar2019 ₹2,365 Cr -

PAT Margins
Y-o-Y

-31.59 %

5 Yr CAGR

-10.44 %

Years PAT Margin(%) % Change
Mar2023 3.79 %
-31.59
Mar2022 5.54 %
-49.54
Mar2021 10.98 %
82.39
Mar2020 6.02 %
2.21
Mar2019 5.89 % -

AUROBINDO PHARMA Earnings Per Share (EPS)
[BOM: 524804|NSE : AUROPHARMA]

Y-o-Y

-27.21 %

5 Yr CAGR

-4.98 %

Years EPS % Change
Mar2023 ₹33
-27.21
Mar2022 ₹45
-50.36
Mar2021 ₹91
87.50
Mar2020 ₹49
20.32
Mar2019 ₹40 -

AUROBINDO PHARMA Return on Capital Employed (ROCE)
[BOM: 524804|NSE : AUROPHARMA]

Y-o-Y

-26.12 %

5 Yr CAGR

-14.98 %

Years ROCE % Change
Mar2023 9.39%
-26.12
Mar2022 12.71%
-57.77
Mar2021 30.1%
60.79
Mar2020 18.72%
4.17
Mar2019 17.97% -

AUROBINDO PHARMA Share Price vs Sensex

Current Share Price : ₹1,017.5
Current MarketCap: ₹ 59,612.4 Cr
Updated EOD on :Mar 18,2024

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

-2.6%

-1.6%

122.3%

SENSEX

-1%

1%

24.9%

AUROBINDO PHARMA related INDICES

BSE Indices1W1M1Y
S&P BSE LARGE MIDCAP -1.9% -0.1% 35.5%
S&P BSE 200 -1.9% -0.1% 35.3%
S&P BSE 250 LARGEMIDCAP -2% -0.4% 35.3%
S&P BSE HEALTHCARE -2.1% -2.4% 59.2%
S&P BSE 500 -2.2% -0.9% 36.5%
NSE Indices1W1M1Y
NIFTY PHARMA -2% 1.3% 62.2%
NIFTY 200 -2% -0.3% 35.5%
NIFTY HEALTHCARE -2.1% -1% 59.4%
NIFTY 500 -2.2% -1% 37.3%
NIFTY LARGE MIDCAP 250 -2.7% -1.8% 41.9%

You may also like the below Video Courses


FAQ about AUROBINDO PHARMA Financials


How the annual revenues of AUROBINDO PHARMA have changed ?

The Revenues of AUROBINDO PHARMA have increased by 5.97% YoY .

How the Earnings per Share (EPS) of AUROBINDO PHARMA have changed?

The Earnings Per Share (EPS) of AUROBINDO PHARMA has decreased by -27.21 % YoY .